Search research articles
Contact Us
Filters
Showing results (361-370 of 611) with videos related to
Page
of 62
Sort By:
Neuroscience
|
April 20, 2000
Metabolic activity of excitatory parafascicular and pedunculopontine inputs to the subthalamic nucleus in a rat model of Parkinson's disease
G Orieux, C Francois, J Féger, et al.
Annals of Neurology
|
July 1, 1990
Deficiency of glutamate dehydrogenase in postmortem brain samples from parkinsonian putamen
J M Cedarbaum, K F Sheu, B J Harding, et al.
Brain : a Journal of Neurology
|
December 1, 1995
Does the enhancement of cholinergic neurotransmission influence brain glucose kinetics and clinical symptomatology in progressive supranuclear palsy?
J Blin, P Mazetti, B Mazoyer, et al.
Neuroscience
|
April 1, 1996
Metabolic activity of the basal ganglia in parkinsonian syndromes in human and non-human primates: a cytochrome oxidase histochemistry study
M Vila, R Levy, M T Herrero, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
February 1, 1996
Saccade disturbances after bilateral lentiform nucleus lesions in humans
A I Vermersch, R M Müri, S Rivaud, et al.
Journal of the Neurological Sciences
|
February 1, 1983
Tyrosine hydroxylase and methionine-enkephalin in the human mesencephalon. Immunocytochemical localization and relationships
P Gaspar, B Berger, M Gay, et al.
Brain Research
|
January 15, 1990
Lack of change in striatal DARPP-32 levels following nigrostriatal dopaminergic lesions in animals and in parkinsonian syndromes in man
R Raisman-Vozari, J A Girault, S Moussaoui, et al.
Neurology
|
January 1, 1985
Dopaminergic receptor sites in human brain: positron emission tomography
J C Baron, D Comar, E Zarifian, et al.
Annals of Neurology
|
May 11, 2000
Levodopa-induced dyskinesias in Parkinson's disease: is sensitization reversible?
B P Bejjani, I Arnulf, S Demeret, et al.
Journal of Neurochemistry
|
August 1, 1980
L-Histidine decarboxylase in the human brain: properties and localization
G Barbin, J M Palacios, M Garbarg, et al.
Page
of 62
Search research articles
Search
Showing results (361-370 of 611) with videos related to
Sort By:
Page
of 62
Neuroscience
|
April 20, 2000
Metabolic activity of excitatory parafascicular and pedunculopontine inputs to the subthalamic nucleus in a rat model of Parkinson's disease
G Orieux, C Francois, J Féger, et al.
Annals of Neurology
|
July 1, 1990
Deficiency of glutamate dehydrogenase in postmortem brain samples from parkinsonian putamen
J M Cedarbaum, K F Sheu, B J Harding, et al.
Brain : a Journal of Neurology
|
December 1, 1995
Does the enhancement of cholinergic neurotransmission influence brain glucose kinetics and clinical symptomatology in progressive supranuclear palsy?
J Blin, P Mazetti, B Mazoyer, et al.
Neuroscience
|
April 1, 1996
Metabolic activity of the basal ganglia in parkinsonian syndromes in human and non-human primates: a cytochrome oxidase histochemistry study
M Vila, R Levy, M T Herrero, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
February 1, 1996
Saccade disturbances after bilateral lentiform nucleus lesions in humans
A I Vermersch, R M Müri, S Rivaud, et al.
Journal of the Neurological Sciences
|
February 1, 1983
Tyrosine hydroxylase and methionine-enkephalin in the human mesencephalon. Immunocytochemical localization and relationships
P Gaspar, B Berger, M Gay, et al.
Brain Research
|
January 15, 1990
Lack of change in striatal DARPP-32 levels following nigrostriatal dopaminergic lesions in animals and in parkinsonian syndromes in man
R Raisman-Vozari, J A Girault, S Moussaoui, et al.
Neurology
|
January 1, 1985
Dopaminergic receptor sites in human brain: positron emission tomography
J C Baron, D Comar, E Zarifian, et al.
Annals of Neurology
|
May 11, 2000
Levodopa-induced dyskinesias in Parkinson's disease: is sensitization reversible?
B P Bejjani, I Arnulf, S Demeret, et al.
Journal of Neurochemistry
|
August 1, 1980
L-Histidine decarboxylase in the human brain: properties and localization
G Barbin, J M Palacios, M Garbarg, et al.
Page
of 62